Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,985 active trials259 approved drugs4,032 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06396143 | Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration | unknown | — | 120 | Zhejiang UniversityOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT03466944 | PUMA (Paediatric Osseous Marrow Assessment)(PUMA) | unknown | — | 12 | Institute of Cancer Research, United KingdomOTHER | 1 | May 1, 2024 |
| clinicaltrials |
| NCT04557020 | Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC | unknown | Phase 3 | 200 | Jiangxi Provincial Cancer HospitalOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT05297591 | Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment(UPLIFT-BC) | unknown | — | 250 | KU LeuvenOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT05371847 | Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity(UPLIFT-BC) | unknown | N/A | 150 | KU LeuvenOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT05821920 | A Safety Study on Posterior Pedicle Screw System(MUST MINI PMS) | unknown | — | 44 | Medacta International SAINDUSTRY | 1 | May 1, 2024 | clinicaltrials |
| NCT06252857 | Real-world Evaluation of Diagnostic and Treatment Strategies in Low-Risk Basal Cell Carcinoma(REDT-BCC) | unknown | — | 142 | Maastricht University Medical CenterOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT06392971 | Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis | unknown | Phase 2 | 120 | First Affiliated Hospital of Chengdu Medical CollegeOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT06393335 | Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research | unknown | Early Phase 1 | 36 | The Children's Hospital of Zhejiang University School of MedicineOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT06394128 | Cangpo Liujun Prescription on Cancer-related Fatigue in Advanced Colorectal Cancer With Spleen Deficiency and Dampness Excess | unknown | Phase 2 | 48 | First People's Hospital of HangzhouOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT06394297 | VIBE - Virtual Image Guided Brachytherapy Emulation for Locally Advanced Cervical Cancer (LACC)(VIBE) | unknown | N/A | 30 | Fundacao ChampalimaudOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT06394427 | Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer | unknown | — | 250 | West China HospitalOTHER | 0 | May 1, 2024 | clinicaltrials |
| NCT06394622 | A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors | unknown | Phase 1 | 12 | Fudan UniversityOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT06395064 | The Effect of Dimenhydrinate on Postoperative Nausea and Vomiting After Abdominal Hysterectomy: Randomized-controlled Trial | unknown | N/A | 160 | Preeyaporn JirakittidulOTHER | 0 | May 1, 2024 | clinicaltrials |
| NCT04527510 | Remote Breast Cancer Screening Study | unknown | — | 6,333 | The First Affiliated Hospital of the Fourth Military Medical UniversityOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT04622007 | Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART)(KICKSTART) | unknown | Phase 2 | 68 | Effector TherapeuticsINDUSTRY | 3 | Apr 30, 2024 | clinicaltrials |
| NCT05804526 | A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours | unknown | Phase 1 / Phase 2 | 82 | RemeGen Co., Ltd.INDUSTRY | 1 | Apr 30, 2024 | clinicaltrials |
| NCT05813028 | The Effect of a Mobile Application on Patient Outcomes in Colorectal Cancer Patients | unknown | N/A | 100 | Ankara UniversityOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT05858385 | Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients | unknown | — | 700 | Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT06206096 | PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC | unknown | Phase 2 | 40 | Chinese PLA General HospitalOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT06272656 | Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma | unknown | — | 200 | Hebei Medical University Third HospitalOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT06391879 | Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma | unknown | — | 300 | Peking University First HospitalOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT06392217 | clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases | unknown | — | 500 | Fudan UniversityOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT05458544 | [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application(LUCIDA) | unknown | Phase 1 / Phase 2 | 26 | FutureChemINDUSTRY | 1 | Apr 29, 2024 | clinicaltrials |
| NCT05579184 | [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2(LUCIDA_2) | unknown | Phase 2 | 20 | FutureChemINDUSTRY | 1 | Apr 29, 2024 | clinicaltrials |
| NCT06252974 | Accurate Diagnosis of the Invasion Depth in ESCC by a Deep Neural Network Analysis of NBI Endoscopy Data | unknown | — | 500 | RenJi HospitalOTHER | 0 | Apr 29, 2024 | clinicaltrials |
| NCT06387238 | Exploration of the Value of PSMA PET/CT in Dynamic Monitoring of the Efficacy of Novel Endocrine Therapy in Patients With Metastatic Hormone Sensitive Prostate Cancer | unknown | N/A | 150 | Peking University First HospitalOTHER | 0 | Apr 29, 2024 | clinicaltrials |
| NCT00831142 | Characterization of Prostate Cancer With 3T MR | unknown | — | 236 | Beth Israel Deaconess Medical CenterOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT01538264 | Blood Flow MRI for Monitoring Brain Tumors(Glioma) | unknown | — | 125 | Beth Israel Deaconess Medical CenterOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06379412 | A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Colorectal Cancer | unknown | — | 200 | Zhujiang HospitalOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06385665 | The Effect of Appropriate Family Companionship on the Physical and Mental Health of Patients With Advanced Breast Cancer | unknown | N/A | 304 | Xin PengOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06385847 | To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer | unknown | Phase 2 | 60 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT04499339 | A Phase I/IIa Clinical Trial to Assess Feasibility, Safety and Antitumor Activity of Autologous SLAMF7 CAR-T Cells in Multiple Myeloma | unknown | Phase 1 / Phase 2 | 38 | Wuerzburg University HospitalOTHER | 3 | Apr 25, 2024 | clinicaltrials |
| NCT04745234 | Mogamulizumab Q4week Dosing in Participants With R/R CTCL | unknown | Phase 2 | 34 | Kyowa Kirin, Inc.INDUSTRY | 5 | Apr 25, 2024 | clinicaltrials |
| NCT04913415 | A Study to Evaluate Routine Chest Tube Management After Minimally Invasive Lung Surgery | unknown | N/A | 160 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)OTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT05865925 | Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 78 | Luye Pharma Group Ltd.INDUSTRY | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06032663 | Use of PET-MR in Head and Neck Cancer Patients - Diagnostic and Therapeutic Applications | unknown | N/A | 10 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06212700 | PRIORITY-CONNECT 2 Pilot Trial | unknown | N/A | 20 | Surgical Outcomes Research Centre (SOuRCe)NETWORK | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06305494 | Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer Survivors | unknown | — | 425 | Khon Kaen UniversityOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06334380 | VR for Surgical Prehabilitation and Rehabilitation(VR-PREP) | unknown | N/A | 30 | Stanford UniversityOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06383559 | Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients | unknown | Phase 2 | 39 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06383793 | Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagogastrostomy in Totally Laparoscopic Total Gastrectomy | unknown | — | 100 | Northern Jiangsu People's HospitalOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06384248 | Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma | unknown | Phase 1 / Phase 2 | 30 | LetolabINDUSTRY | 0 | Apr 25, 2024 | clinicaltrials |
| NCT06384950 | Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma | unknown | N/A | 450 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Apr 25, 2024 | clinicaltrials |
| NCT03558048 | The Effect of IBD Flares on Serum PSA | unknown | — | 400 | Northwestern UniversityOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT05056051 | Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus | unknown | N/A | 200 | Northwestern UniversityOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT05893368 | New Model for Integrating Person-based Care (PbC) in the Treatment of Advanced HER2-negative Breast Cancer(PERGIQUAL) | unknown | — | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT05982626 | Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer | unknown | N/A | 10 | Huashan HospitalOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT05989724 | A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors | unknown | Phase 1 | 150 | Qurgen Inc.INDUSTRY | 1 | Apr 24, 2024 | clinicaltrials |
| NCT06243432 | Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast Cancer(CYCLHER) | unknown | — | 600 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 24, 2024 | clinicaltrials |
Data updated 24 days agoSource updated May 2, 2024source: clinicaltrials